The LENS Trial: ‘Welcoming Back an Old Friend’

Akshay Jain, MD, and David Preiss, PhD, MRCP, discuss the results of the LENS trial which showed that fenofibrate slows diabetic retinopathy progression.
Medscape Diabetes & Endocrinology